Shanghai Sanyou Medical Co., Ltd. (688085.SS)
CNY 17.21
(2.62%)
CNY 17.21
(2.62%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -649.36 Million CNY | -93.82% |
| 2022 | -335.04 Million CNY | 11.18% |
| 2021 | -377.23 Million CNY | -45.65% |
| 2020 | -258.99 Million CNY | -591.56% |
| 2019 | -37.45 Million CNY | -45.54% |
| 2018 | -25.73 Million CNY | 25.26% |
| 2017 | -34.42 Million CNY | 36.44% |
| 2016 | -54.17 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -481.84 Million CNY | 12.18% |
| 2024 Q1 | -548.66 Million CNY | 15.51% |
| 2024 Q3 | -414.08 Million CNY | 14.06% |
| 2023 Q1 | -563.12 Million CNY | -68.07% |
| 2023 FY | -649.36 Million CNY | -93.82% |
| 2023 Q4 | -649.36 Million CNY | -1.57% |
| 2023 Q3 | -639.33 Million CNY | -10.24% |
| 2023 Q2 | -579.93 Million CNY | -2.99% |
| 2022 Q4 | -335.04 Million CNY | 12.87% |
| 2022 Q3 | -384.54 Million CNY | 0.6% |
| 2022 Q2 | -386.86 Million CNY | 26.47% |
| 2022 Q1 | -526.11 Million CNY | -39.47% |
| 2022 FY | -335.04 Million CNY | 11.18% |
| 2021 Q4 | -377.23 Million CNY | 17.04% |
| 2021 Q2 | -500.53 Million CNY | 1.5% |
| 2021 FY | -377.23 Million CNY | -45.65% |
| 2021 Q3 | -454.69 Million CNY | 9.16% |
| 2021 Q1 | -508.17 Million CNY | -93.63% |
| 2020 Q3 | -760.54 Million CNY | 13.14% |
| 2020 Q1 | -37.72 Million CNY | -0.74% |
| 2020 FY | -258.99 Million CNY | -591.56% |
| 2020 Q4 | -262.45 Million CNY | 65.49% |
| 2020 Q2 | -875.59 Million CNY | -2220.7% |
| 2019 Q4 | -37.45 Million CNY | 0.0% |
| 2019 FY | -37.45 Million CNY | -45.54% |
| 2019 Q2 | -38.33 Million CNY | -133.56% |
| 2019 Q1 | 114.21 Million CNY | 543.84% |
| 2019 Q3 | - CNY | 100.0% |
| 2018 FY | -25.73 Million CNY | 25.26% |
| 2018 Q4 | -25.73 Million CNY | 0.0% |
| 2017 FY | -34.42 Million CNY | 36.44% |
| 2016 FY | -54.17 Million CNY | 0.0% |